Showing results (91-100 of 275) with videos related to

Sort By:
Pageof 28
Scientific Reports|October 24, 2023
Performance of baseline FDG-PET/CT radiomics for prediction of bone marrow minimal residual disease status in the LyMa-101 trialCaroline Bodet-Milin, Cyrille Morvant, Thomas Carlier, et al.
Blood|August 3, 2018
An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphomaFranck Morschhauser, Gilles Salles, Steven Le Gouill, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 6, 2009
Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin's lymphoma: a reflection of disease infiltration or just inflammation?Pierre Y Salaun, Thomas Gastinne, Caroline Bodet-Milin, et al.
European Journal of Nutrition|January 11, 2022
Glycemic response, satiety, gastric secretions and emptying after bread consumption with water, tea or lemon juice: a randomized crossover intervention using MRIDaniela Freitas, François Boué, Mourad Benallaoua, et al.
Food Research International (Ottawa, Ont.)|April 9, 2026
Tea, coffee, and cocoa delay milk gastric coagulation in a biomimetic in vitro system (NERDT™) by hindering both acid- and pepsin-induced milk gelationIsuri A Jayawardana, Amélie Deglaire, Olivia Ménard, et al.
Blood|July 10, 2014
PRIMA-1Met induces myeloma cell death independent of p53 by impairing the GSH/ROS balanceBenoît Tessoulin, Géraldine Descamps, Philippe Moreau, et al.
Blood|April 28, 2006
Mcl-1L cleavage is involved in TRAIL-R1- and TRAIL-R2-mediated apoptosis induced by HGS-ETR1 and HGS-ETR2 human mAbs in myeloma cellsEmmanuelle Menoret, Patricia Gomez-Bougie, Alexandrine Geffroy-Luseau, et al.
Blood|June 26, 2004
VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosisSteven Le Gouill, Klaus Podar, Martine Amiot, et al.
Blood Cells, Molecules & Diseases|February 21, 2012
Critical role of the NOTCH ligand JAG2 in self-renewal of myeloma cellsDavid Chiron, Sophie Maïga, Géraldine Descamps, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 21, 2023
Validation of the ΔSUVmax for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical TrialEmmanuel Itti, Paul Blanc-Durand, Alina Berriolo-Riedinger, et al.
Pageof 28